MedPath

A RANDOMIZED CONTROLLED TRIAL OF ROPIVACAINE INJECTION AFTER ROBOTIC THYROIDECTOMY

Not Applicable
Completed
Conditions
Neoplasms
Registration Number
KCT0001085
Lead Sponsor
Seoul National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
108
Inclusion Criteria

1. Plan to robotic thyroidectomy
2. Patients agreed to this study with sign a consent form

Exclusion Criteria

1. Amide- local anaesthetic hypersensitivity patients.
2. Users with Anti coagulation including aspirin and anti- platelet agents
3. Pregnats wemans
4. Uncontrolled hypertension or diabetus patients.
5. Severe coagulopathy, cardiopulmanary disease, chronic renal failure patients.
6. Stroke history patients.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
post operative pain score
Secondary Outcome Measures
NameTimeMethod
analgesic requirements ;Postoperative adverse effect
© Copyright 2025. All Rights Reserved by MedPath